I agree that this site is using cookies. You can find further informations here.
X
Kaltenthaler, Eva
107  results:
Search for persons X
?
1

Delphi consensus reached to produce a decision tool for Sel..:

Pandor, Abdullah ; Kaltenthaler, Eva ; Martyn-St James, Marrissa...
Journal of Clinical Epidemiology.  114 (2019)  - p. 22-29 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Barriers and Facilitators to the Implementation of Interven..:

Atienzo, Erika E. ; Kaltenthaler, Eva ; Baxter, Susan K.
Trauma, Violence & Abuse.  19 (2018)  4 - p. 420-430 , 2018
Link: https://www.jstor.org/st..
 
?
3

OP75 Tailoring Review Methods: Scope, Timescale And Needs O..:

Cooper, Katy ; Harnan, Susan ; Preston, Louise...
International Journal of Technology Assessment in Health Care.  34 (2018)  S1 - p. 27-27 , 2018
Link: https://doi.org/10.1017/..
 
?
4

EMA and NICE Appraisal Processes for Cancer Drugs: Current ..:

Dickson, Rumona ; Boland, Angela ; Duarte, Rui...
Applied Health Economics and Health Policy.  16 (2018)  4 - p. 429-432 , 2018
Link: https://doi.org/10.1007/..
 
?
5

Ibrutinib for Treating Relapsed or Refractory Mantle Cell L..:

Tappenden, Paul ; Simpson, Emma ; Hamilton, Jean...
PharmacoEconomics.  37 (2018)  3 - p. 333-343 , 2018
Link: https://doi.org/10.1007/..
 
?
6

Nature and reporting characteristics of UK health technolog..:

Carroll, Christopher ; Kaltenthaler, Eva
BMC Medical Research Methodology.  18 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
7

Pembrolizumab for Locally Advanced or Metastatic Urothelial..:

Ren, Shijie ; Squires, Hazel ; Hock, Emma...
PharmacoEconomics.  37 (2018)  9 - p. 1073-1080 , 2018
Link: https://doi.org/10.1007/..
 
?
8

What Is the Evidence from Past National Institute of Health..:

Carroll, Christopher ; Houten, Rachel ; Boland, Angela..
Value in Health.  21 (2018)  3 - p. 341-350 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Patient-Reported Outcome Measures in Carotid Artery Revascu..:

Essat, Munira ; Aber, Ahmed ; Phillips, Patrick...
Annals of Vascular Surgery.  50 (2018)  - p. 275-283 , 2018
Link: https://doi.org/10.1016/..
 
?
10

VP15 A Comparison Of Reporting In United Kingdom Health Tec..:

Carroll, Christopher ; Kaltenthaler, Eva
International Journal of Technology Assessment in Health Care.  33 (2017)  S1 - p. 152-153 , 2017
Link: https://doi.org/10.1017/..
 
?
11

PP024 Changes In Reporting Characteristics Of Systematic Re..:

Kaltenthaler, Eva ; Carroll, Christopher
International Journal of Technology Assessment in Health Care.  33 (2017)  S1 - p. 80-81 , 2017
Link: https://doi.org/10.1017/..
 
?
12

Adalimumab for Treating Moderate-to-Severe Hidradenitis Sup..:

Tappenden, Paul ; Carroll, Christopher ; Stevens, John W....
PharmacoEconomics.  35 (2017)  8 - p. 805-815 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER..:

Squires, Hazel ; Pandor, Abdullah ; Thokala, Praveen...
PharmacoEconomics.  36 (2017)  1 - p. 29-38 , 2017
Link: https://doi.org/10.1007/..
 
?
14

VP166 Selecting Rapid Review Methods For Health Technology ..:

Kaltenthaler, Eva ; Cooper, Katy ; Martyn-St James, Marrissa..
International Journal of Technology Assessment in Health Care.  33 (2017)  S1 - p. 225-226 , 2017
Link: https://doi.org/10.1017/..
 
?
15

OP27 Patient-Reported Outcome Measures In Carotid Artery Re..:

Essat, Munira ; Aber, Ahmed ; Phillips, Patrick...
International Journal of Technology Assessment in Health Care.  33 (2017)  S1 - p. 12-13 , 2017
Link: https://doi.org/10.1017/..
 
1-15